Connect with us

Business

Ark Invest analyst breaks down Adaptive Biotechnologies and Invitae – CNBC

In a CNBC interview, Ark Invest analyst Simon Barnett explains the firm’s belief in Adaptive Biotechnologies and Invitae.

Published

on

Article feature image
ADVERTISEMENT

Ark Invest analyst Simon Barnett on Monday explained the firm’s approach to what it calls the genomic revolution, breaking down two of its favorite holdings: Adaptive Biotechnologies and Invitae.
In an interview on CNBC’s “Closing Bell,” Barnett said the Cathie Wood-led Ark Invest sees major potential for investors in the branch of molecular biology known as genomics, calling it “one of the most transformative investment opportunities of the century.”
Ark’s family of funds includes the Genomic Revolution…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Goldman Sachs manager quits after Dogecoin profit – Fox Business
‘It’s really frustrating’: Worker shortages are putting more money in employees pockets but could slow the economy – USA TODAY
Article feature image
CHP arrests man they say sat in back seat of Tesla while it drove, driverless, on freeway – San Francisco Chronicle